gene therapy Archives - Express Pharma

CRISPR-based innovations drive $21 bn in pharma licensing deals over five years: GlobalData

US approves first gene therapy for children with rare genetic disease

EMA seeks to issue guidance on liver damage from Novartis’s gene therapy

US FDA approves Bluebird Bio’s gene therapy for rare neurological disorder

Pfizer to start US trial of gene therapy as FDA lifts hold

Novartis and Voyager Therapeutics reach licence option agreement for next-generation gene therapy vectors for neurological diseases

CPhI and Informa Pharma Intelligence conclude 3rd Biopharma Conclave

TSHA-102 from Taysha gets rare paediatric disease and orphan drug designations for Rett syndrome

Biogen to study Spinraza in combination with $2-mn Novartis drug

Noga Therapeutics and Lonza to develop Autologous Lentiviral Gene Therapy on the Cocoon Platform